Zobrazeno 1 - 10
of 97
pro vyhledávání: '"Panagiotis Papathanasopoulos"'
Autor:
Petrus J. de Vries, Elena Belousova, Mirjana P. Benedik, Tom Carter, Vincent Cottin, Paolo Curatolo, Maria Dahlin, Lisa D'Amato, Guillaume Beaure d'Augères, José C. Ferreira, Martha Feucht, Carla Fladrowski, Christoph Hertzberg, Sergiusz Jozwiak, John A. Lawson, Alfons Macaya, Ruben Marques, Rima Nabbout, Finbar O'Callaghan, Jiong Qin, Valentin Sander, Matthias Sauter, Seema Shah, Yukitoshi Takahashi, Renaud Touraine, Sotiris Youroukos, Bernard Zonnenberg, John C. Kingswood, Anna C. Jansen, Nobuo Shinohara, Shigeo Horie, Masaya Kubota, Jun Tohyama, Katsumi Imai, Mari Kaneda, Hideo Kaneko, Yasushi Uchida, Tomoko Kirino, Shoichi Endo, Yoshikazu Inoue, Katsuhisa Uruno, Ayse Serdaroglu, Zuhal Yapici, Banu Anlar, Sakir Altunbasak, Olga Lvova, Oleg Valeryevich Belyaev, Oleg Agranovich, Elena Vladislavovna Levitina, Yulia Vladimirovna Maksimova, Antonina Karas, Yuwu Jiang, Liping Zou, Kaifeng Xu, Yushi Zhang, Guoming Luan, Yuqin Zhang, Yi Wang, Meiling Jin, Dingwei Ye, Weiping Liao, Liemin Zhou, Jie Liu, Jianxiang Liao, Bo Yan, Yanchun Deng, Li Jiang, Zhisheng Liu, Shaoping Huang, Hua Li, Kijoong Kim, Pei-Lung Chen, Hsiu-Fen Lee, Jeng-Dau Tsai, Ching-Shiang Chi, Chao-Ching Huang, Kate Riney, Deborah Yates, Patrick Kwan, Surachai Likasitwattanakul, Charcrin Nabangchang, Lunliya Thampratankul Krisnachai Chomtho, Kamornwan Katanyuwong, Somjit Sriudomkajorn, Jo Wilmshurst, Reeval Segel, Tal Gilboa, Michal Tzadok, Aviva Fattal-Valevski, Panagiotis Papathanasopoulos, Antigone Syrigou Papavasiliou, Stylianos Giannakodimos, Stylianos Gatzonis, Evangelos Pavlou, Meropi Tzoufi, A. M. H. Vergeer, Marc Dhooghe, Hélène Verhelst, Filip Roelens, Marie Cecile Nassogne, Pierre Defresne, Liesbeth De Waele, Patricia Leroy, Nathalie Demonceau, Benjamin Legros, Patrick Van Bogaert, Berten Ceulemans, Lina Dom, Pierre Castelnau, Anne De Saint Martin, Audrey Riquet, Mathieu Milh, Claude Cances, Jean-Michel Pedespan, Dorothee Ville, Agathe Roubertie, Stéphane Auvin, Patrick Berquin, Christian Richelme, Catherine Allaire, Sophie Gueden, Sylvie Nguyen The Tich, Bertrand Godet, Maria Luz Ruiz Falco Rojas, Jaume Campistol Planas, Antonio Martinez Bermejo, Patricia Smeyers Dura, Susana Roldan Aparicio, Maria Jesus Martinez Gonzalez, Javier Lopez Pison, Manuel Oscar Blanco Barca, Eduardo Lopez Laso, Olga Alonso Luengo, Francisco Javier Aguirre Rodriguez, Ignacio Malaga Dieguez, Ana Camacho Salas, Itxaso Marti Carrera, Eduardo Martinez Salcedo, Maria Eugenia Yoldi Petri, Ramon Cancho Candela, Ines da Conceicao Carrilho, Jose Pedro Vieira, José Paulo da Silva Oliveira Monteiro, Miguel Jorge Santos de Oliveira Ferreira Leao, Catarina Sofia Marceano Ribeiro Luis, Carla Pires Mendonca, Milda Endziniene, Jurgis Strautmanis, Inga Talvik, Maria Paola Canevini, Antonio Gambardella, Dario Pruna, Salvatore Buono, Elena Fontana, Bernardo Dalla Bernardina, Carmen Burloiu, Iuliu Stefan Bacos Cosma, Mihaela Adela Vintan, Laura Popescu, Karel Zitterbart, Jaroslava Payerova, Ladislav Bratsky, Zuzana Zilinska, Ursula Gruber-Sedlmayr, Matthias Baumann, Edda Haberlandt, Kevin Rostasy, Ekaterina Pataraia, Frances Elmslie, Clare Ann Johnston, Pamela Crawford, Peter Uldall, Paul Uvebrant, Olof Rask, Marit Bjoernvold, Eylert Brodtkorb, Andreas Sloerdahl, Ragnar Solhoff, Martine Sofie Gilje Jaatun, Marek Mandera, Elzbieta Janina Radzikowska, Mariusz Wysocki, Michael Fischereder, Gerhard Kurlemann, Bernd Wilken, Adelheid Wiemer-Kruel, Klemens Budde, Klaus Marquard, Markus Knuf, Andreas Hahn, Hans Hartmann, Andreas Merkenschlager, Regina Trollmann
Publikováno v:
Frontiers in Neurology, Vol 11 (2020)
Background: Knowledge is increasing about TSC-Associated Neuropsychiatric Disorders (TAND), but little is known about the potentially confounding effects of intellectual ability (IA) on the rates of TAND across age, sex, and genotype. We evaluated TA
Externí odkaz:
https://doaj.org/article/0d2a822147c14b50947f4f220e1b67cb
Autor:
Grigorios Nasios, Lambros Messinis, Mary H Kosmidis, Petros Zampakis, Panagiotis Papathanasopoulos
Publikováno v:
Dialogues in Clinical Neuroscience & Mental Health, Vol 1, Iss s1 (2018)
Cognitive dysfunction is common in multiple sclerosis (MS) patients and significantly influences their daily functioning abilities and quality of life. Cognitive impairment rates of between 30-60 % have been reported, whereas lifetime prevalence rate
Externí odkaz:
https://doaj.org/article/f99f7eb90cc94f2b86b5843e0fefec09
Publikováno v:
Behavioural Neurology, Vol 2018 (2018)
Multiple sclerosis (MS) affects cognition in the majority of patients. A major aspect of the disease is brain volume loss (BVL), present in all phases and types (relapsing and progressive) of the disease and linked to both motor and cognitive disabil
Externí odkaz:
https://doaj.org/article/8d7a3e49085446d089ab0023a58d1786
Autor:
Lambros Messinis, Panagiotis Papathanasopoulos, Mary H. Kosmidis, Grigorios Nasios, Maria Kambanaros
Publikováno v:
Behavioural Neurology, Vol 2018 (2018)
Externí odkaz:
https://doaj.org/article/5f300c3c9b9f48c09ef5226b3b14bedd
Autor:
Lambros Messinis, Grigorios Nasios, Mary H. Kosmidis, Petros Zampakis, Sonia Malefaki, Katerina Ntoskou, Anastasia Nousia, Christos Bakirtzis, Nikolaos Grigoriadis, Philippos Gourzis, Panagiotis Papathanasopoulos
Publikováno v:
Behavioural Neurology, Vol 2017 (2017)
Cognitive impairment is frequently encountered in multiple sclerosis (MS) affecting between 40–65% of individuals, irrespective of disease duration and severity of physical disability. In the present multicenter randomized controlled trial, fifty-e
Externí odkaz:
https://doaj.org/article/7b7382198a0a4810af4126de6484e555
Autor:
Georgios Tsivgoulis, Aristeidis H Katsanos, Dimitris Mavridis, Nikolaos Grigoriadis, Efthymios Dardiotis, Ioannis Heliopoulos, Panagiotis Papathanasopoulos, Theodoros Karapanayiotides, Constantinos Kilidireas, Georgios M Hadjigeorgiou, Konstantinos Voumvourakis, HELANI (Hellenic Academy of Neuroimmunology)
Publikováno v:
PLoS ONE, Vol 11, Iss 9, p e0163296 (2016)
Although Fingolimod (FGD) and Natalizumab (NTZ) appear to be effective in relapsing-remitting multiple sclerosis (RRMS), they have never been directly compared in a randomized clinical trial (RCT).We evaluated the comparative efficacy of FGD vs. NTZ
Externí odkaz:
https://doaj.org/article/ed0cd20841144b60a982bc8f7d566f9d
Autor:
Athanasia Mouzaki, Maria Rodi, Nikolaos Dimisianos, Andreas Emmanuil, Dimitra Kalavrizioti, Rosa Lagoudaki, Nikolaos C Grigoriadis, Panagiotis Papathanasopoulos
Publikováno v:
PLoS ONE, Vol 11, Iss 3, p e0151411 (2016)
Externí odkaz:
https://doaj.org/article/a5e8b13d97d04f6ba6b5a64df74a8556
Autor:
Georgios Tsivgoulis, Aristeidis H. Katsanos, Nikolaos Grigoriadis, Georgios M. Hadjigeorgiou, Ioannis Heliopoulos, Panagiotis Papathanasopoulos, Efthimios Dardiotis, Constantinos Kilidireas, Konstantinos Voumvourakis
Publikováno v:
Therapeutic Advances in Neurological Disorders, Vol 8 (2015)
Objectives: Brain atrophy is associated with cognitive deficits in patients with clinically isolated syndrome (CIS) and can predict conversion to clinical definite multiple sclerosis. The aim of the present meta-analysis was to evaluate the effect of
Externí odkaz:
https://doaj.org/article/43ab91ac6d5a4f9f8ff5d2a30239b5cc
Autor:
Athanasia Mouzaki, Maria Rodi, Nikolaos Dimisianos, Andreas Emmanuil, Dimitra Kalavrizioti, Rosa Lagoudaki, Nikolaos C Grigoriadis, Panagiotis Papathanasopoulos
Publikováno v:
PLoS ONE, Vol 10, Iss 8, p e0135434 (2015)
Multiple sclerosis (MS) is an inflammatory, demyelinating disease of the central nervous system. Effector T helper cells, mainly Th1 and Th17, cytotoxic T-cells, B-cells, macrophages, microglia, and the cytokines they secrete, are implicated in the i
Externí odkaz:
https://doaj.org/article/bcb94950b51d4689850abf56dc964bd9
Autor:
Georgios Tsivgoulis, Aristeidis H Katsanos, Nikolaos Grigoriadis, Georgios M Hadjigeorgiou, Ioannis Heliopoulos, Panagiotis Papathanasopoulos, Constantinos Kilidireas, Konstantinos Voumvourakis, Efthimios Dardiotis, HELANI (Hellenic Academy of Neuroimmunology)
Publikováno v:
PLoS ONE, Vol 10, Iss 12, p e0144538 (2015)
A number of officially approved disease-modifying drugs (DMD) are currently available for the early intervention in patients with relapsing-remitting multiple sclerosis (RRMS). The aim of the present study was to systematically evaluate the effect of
Externí odkaz:
https://doaj.org/article/b382c3de26c345c9a1ab83200f5be200